Intrum (INTRUM) Q4 2024 earnings summary

Executive summary

• Q4 2024 and full-year results showed solid business performance, with strong progress on internal and external initiatives, including cost savings, improved Servicing margins, and strategic advances such as U.S. Chapter 11 plan confirmation and Swedish reorganisation.

• Servicing delivered its second strongest quarter in five years, with EBIT up 26% year-over-year and margin rising to 30% from 23% last year.

• Collections outperformed both active and original forecasts, despite a smaller proprietary book.

• Ophelos AI integration expanded, delivering cost and collection improvements, with rollout to cover more markets in 2025.

• Board does not intend to propose a dividend for 2024.

Financial highlights

• Q4 2024 income was SEK 4,825M, down 4% year-over-year; full-year income up 2% to SEK 18,033M.

• Adjusted EBIT up 5% to SEK 1,696M in Q4 and up 2% to SEK 4,548M for the year; unadjusted EBIT down 58% in Q4 due to nonrecurring costs.

• Net loss for Q4 was SEK -767M and SEK -914M attributable to shareholders, impacted by significant one-time items and discontinued operations.

• Cash and cash equivalents at year-end: SEK 2.5bn.

• CapEx deployed for the year was SEK 1.7bn, slightly below the SEK 2bn target.

Outlook and guidance

• Recapitalisation process expected to complete in Q2 2025, with deleveraging to follow in the second half and into 2026.

• Expectation of further cost reductions and margin improvement in 2025, with continued focus on operational excellence and capital-light model.

• Guidance to achieve a leverage ratio of 3.5x by end of 2026 remains unchanged.

• Ophelos AI rollout to reach over 9 markets by year-end 2025, targeting 7.4M cases.

• Focus on producing meaningful positive Net Income in 2025 and beyond.